Analystreport

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its price target lowered by analysts at Needham & Company LLC from $75.00 to $62.00.

Rocket Pharmaceuticals, Inc.  (RCKT) 
Last rocket pharmaceuticals, inc. earnings: 3/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: rocketpharma.com